GGHC
PROF

Gilder Gagnon Howe & Co’s Profound Medical PROF Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-145,613
Closed -$588K – 259
2022
Q3 		$588K Sell
145,613
-902
-0.6% -$6.09K 0.01% 215
2022
Q2 		$1.07M Sell
146,515
-16,732
-10% -$132K 0.02% 195
2022
Q1 		$1.47M Buy
163,247
+1,726
+1% +$16.6K 0.01% 236
2021
Q4 		$1.81M Sell
161,521
-87
-0.1% -$1.09K 0.01% 273
2021
Q3 		$2.37M Sell
161,608
-35,034
-18% -$534K 0.01% 294
2021
Q2 		$3.22M Buy
196,642
+22,858
+13% +$425K 0.02% 284
2021
Q1 		$3.5M Buy
173,784
+40,368
+30% +$968K 0.02% 259
2020
Q4 		$2.74M Sell
133,416
-515
-0.4% -$9.47K 0.01% 239
2020
Q3 		$2.36M Buy
+133,931
New +$2.13M 0.01% 233

Other funds holding PROF

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Gilder Gagnon Howe & Co's PROF Position: Q4 2022 in Review

Gilder Gagnon Howe & Co sold out of Profound Medical (PROF) in Q4 2022, closing a stake of 145,613 shares — an estimated $588K sold.

Gilder Gagnon Howe & Co first reported a position in PROF in Q3 2020 and held it in 9 quarters. The position peaked at $3.5M in Q1 2021. 34 funds tracked by Wall St. Rank hold PROF as of Q4 2022.

  • Gilder Gagnon Howe & Co reported no remaining Profound Medical position as of Q4 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 145,613 Profound Medical shares in Q4 2022, an estimated $588K.
  • Gilder Gagnon Howe & Co first reported a position in Profound Medical in Q3 2020 and held it in 9 quarters.
  • Gilder Gagnon Howe & Co's Profound Medical position peaked at $3.5M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Profound Medical as of Q4 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2022, filed 14 Feb 2023.